Rivadel 2.5 is a tablet from Delta Pharma Limited, with the generic name Rivaroxaban. It is an oral anticoagulant, sometimes called a blood thinner.
There are 19 brands of Rivaroxaban listed in Bangladesh. By unit price, Rivadel 2.5 is among the cheapest of them.
What is Rivadel 2.5 Tablet?
Rivadel 2.5 2.5 mg tablet is a medicine made by Delta Pharma Limited. Anti-coagulants such as this are used in conditions where the risk of unwanted clots is a concern. Doctors prescribe it for adults after an acute coronary syndrome with raised cardiac biomarkers, alongside aspirin or aspirin with clopidogrel or ticlopidine. Ask your doctor or pharmacist if you are unsure why it has been prescribed for you.
Uses of Rivadel 2.5
It is an oral anticoagulant, sometimes called a blood thinner. Rivadel 2.5 is used as an anticoagulant. It is not a painkiller or a general tonic and should not be used for other purposes. Ask your doctor what Rivadel 2.5 is being prescribed for in your case.
How to use Rivadel 2.5
Swallow the tablet as advised, and keep to the schedule your doctor sets. Swallow the tablet with water. Rivadel 2.5 is taken by mouth. Do not take more than prescribed. Tell your doctor about all other medicines you take. Follow the doctor's instructions exactly and do not change the dose yourself.
Side effects of Rivadel 2.5
Seek medical help for unusual or persistent bleeding, and ask your doctor about any other effects you notice. Your doctor or pharmacist can explain what warning signs to watch for. In people with nonvalvular atrial fibrillation, stopping the medicine has been linked to an increased risk of stroke. Tell your doctor promptly about any unusual or prolonged bleeding. Tell your doctor if any side effect bothers you or does not go away.
Safety and precautions
Pregnant or breastfeeding women should speak to their doctor first. It must not be used if you are allergic to Rivaroxaban or have active pathological bleeding. The risk of bleeding is higher in people with bleeding disorders, uncontrolled severe high blood pressure, certain gastrointestinal diseases, vascular retinopathy, bronchiectasis or a history of pulmonary bleeding, so these should be discussed with the doctor first. Ask your doctor first if any of these apply to you.
Frequently asked questions
What is Rivadel 2.5 used for?
It is an oral anticoagulant, sometimes called a blood thinner. Rivadel 2.5 is used as an anticoagulant.
How do I use Rivadel 2.5 correctly?
Swallow the tablet as advised, and keep to the schedule your doctor sets. Swallow the tablet with water.
What are the side effects of Rivadel 2.5?
Seek medical help for unusual or persistent bleeding, and ask your doctor about any other effects you notice. Your doctor or pharmacist can explain what warning signs to watch for.
Who should be careful with Rivadel 2.5?
Pregnant or breastfeeding women should speak to their doctor first. It must not be used if you are allergic to Rivaroxaban or have active pathological bleeding.
For the prevention of atherothrombotic events in adult patients after an Acute Coronary Syndrome (ACS) with elevated cardiac biomarkers (Troponin or CK-MB). It is co-administered with Aspirin alone or with Aspirin plus Clopidogrel orTidopidine.
For the prevention of atherothrombotic events in adult patients after an Acute Coronary Syndrome (ACS) with elevated cardiac biomarkers (Troponin or CK-MB). It is co-administered with Aspirin alone or with Aspirin plus Clopidogrel orTidopidine.
Rivaroxaban 10-20 mg:
To reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation
Deep vein thrombosis (DVT) & pulmonary embolism (PE) and reduction in the risk of recurrence of DVT and of PE
For the prophylaxis of DVT, which may lead to PE in patients undergoing knee or hip replacement surgery
Pharmacology
Rivaroxaban is a highly selective direct factor Xa inhibitor. Inhibition of factor Xa interrupts the intrinsic and extrinsic pathway of the blood coagulation cascade, inhibits thrombin formation. Rivaroxaban does not inhibit thrombin (activated factor II) and no effects on platelets have been demonstrated.
Dosage & Administration
Rivaroxaban 2.5 mg:
The recommended dose: 2.5 mg twice daily. Patients should also take a daily dose of 75-100 mg Aspirin or a daily dose of 75-100 mg Aspirin in addition to either a daily dose of 75 mg clopidogrel or a standard daily dose of ticlopidine.
Rivaroxaban 10-20 mg:
Nonvalvular Atrial Fibrillation: For patients with Creatinin Clearance >50 mL/min: 20 mg orally, once daily with the evening meal. For patients with Creatinin Clearance 15-50 ml/min: 15 mg orally, once daily with the evening meal.
Treatment of DVT & PE: 15 mg orally twice daily with food for the first 21 days for the initial treatment of acute DVT or PE. After the initial treatment period, 20 mg orally once daily with food for the remaining treatment.
Prevention in the risk of recurrence of DVT and of PE: 20 mg once daily with food.
Prophylaxis of DVT following Hip replacement surgery: 10 mg once daily for 35 days.
Prophylaxis of DVT following knee replacement surgery: 10 mg once daily for 12 days.
May be taken with or without food.
Interaction
Concomitant use with drugs that are combined P-gp and CYP3A4 inhibitors (ketoconazole, ritonavir, clarithromycin, erythromycin, fluconazole, diltiazem, verapamil, dronedarone) increases in Rivaroxaban exposure and pharmacodynamic effects (i.e., factor Xa inhibition and PT prolongation), that’s why should be avoided. Co-administration of Rivaroxaban with a combined P-gp and strong CYP3A4 inducer (e.g., rifampicin, phenytoin, carbamazepine) decreases the efficacy of Rivaroxaban and also should be avoided. The concomitant use of other drugs like anti-platelet agents, heparin, fibrinolytic therapy, NSAIDs may cause an increased risk of bleeding.
Contraindications
It is contraindicated in patients with known hypersensitivity of Rivaroxaban or any of the excipients of the product. It is also contraindicated in patients with active pathological bleeding.
Side Effects
The most common side effects of Rivaroxaban have increased chance of bleeding, spinal or epidural hematoma and increased risk of stroke after discontinuation in nonvalvular atrial fibrillation.
Pregnancy & Lactation
Rivaroxaban is a pregnancy category C drug. There are no adequate or well-controlled studies of Rivaroxaban in pregnant women, and dosing for pregnant women has not been established. It is not known if Rivaroxaban is excreted in human milk. The safety and efficacy of Rivaroxaban has not been established in breastfeeding women.
Precautions & Warnings
Early discontinuation of Rivaroxaban, in the absence of adequate alternative anticoagulation increases the risk of thrombotic events. Rivaroxaban increases the risk of bleeding that can be fatal in presence of following risk factors- bleeding disorders, uncontrolled severe arterial hypertension, gastrointestinal disease (e.g., inflammatory bowel disease, oesophagitis, gastritis and gastroesophageal reflux disease), vascular retinopathy, bronchiectasis, history of pulmonary bleeding. Signs or symptoms of neurological impairment should be monitored in case of neuraxial anesthesia (spinal/epidural anesthesia) or spinal puncture as epidural or spinal hematoma can occur. Rivaroxaban is not recommended in patients with pulmonary embolism who present with hemodynamic instability or who may receive thrombolysis or pulmonary embolectomy.
Overdose Effects
Overdose of Rivaroxaban may lead to hemorrhage. Rivaroxaban systemic exposure is not further increased at single doses >50 mg due to limited absorption. A specific antidote for Rivaroxaban is not available. The use of activated charcoal to reduce absorption in case of Rivaroxaban overdose may be considered. Partial reversal of laboratory anticoagulation parameters may be achieved with use of plasma products.
Storage Conditions
Store in a cool (below 30°C) & dry place protected from light. Keep away from the reach of children.
Alternative brands of Rivaroxaban
Other brands with the same generic name, cheapest first.